Pediatric Molecular Pathology

Recent advances in molecular technology vastly expanded the possibilities for personalized medicine. Benefiting from these techniques requires thoughtful tests, coupled with a deep understanding of the clinical implications of molecular alterations. The promise of personalized medicine is to match specific aberrations in a patient’s tumor DNA to the most accurate diagnosis, the most up-to-date prognosis and the most effective therapy available. Many pediatric tumors and vascular malformations are defined by characteristic genetic changes that are best assessed by evolving molecular technologies. The correct diagnosis is essential to offering patients both the most accurate prognosis and the most effective therapy. To that end, we have designed a suite of molecular tests that will take the practice of diagnostic pediatric pathology to the next level with multiplex testing that delivers more actionable information with a better turnaround time.

    Related Conference of Pediatric Molecular Pathology

    April 25-26, 2024

    22nd European Pathology Congress

    London, UK
    August 21-22, 2024

    4th World Pathology Conference

    Amsterdam, Netherlands
    September 23-24, 2024

    22nd Annual Pathology Congress

    Dubai, UAE

    Pediatric Molecular Pathology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in